CoLucid

Labrys Biologics

This biopharmaceutical company develops monoclonal antibody therapeutics for the preventive treatment of chronic and episodic migraines in patients.

Biohaven

This biopharmaceutical company develops therapeutics for patients with debilitating neurological, neuroinflammatory, and metabolic diseases, as well as immunological and oncology disorders.

Miist Therapeutics

This company develops inhaled drug delivery devices providing rapid symptom relief for patients suffering from migraines or seeking smoking cessation.

Brise Pharmaceuticals Co., LTD.

This biopharmaceutical company develops analgesic treatments for patients with severe pain conditions including migraine, neuropathic pain, and musculoskeletal pain.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

Acumen Pharmaceuticals

This biopharmaceutical company develops novel targeted therapies for patients with Alzheimer's disease by targeting toxic soluble amyloid beta oligomers.

Coherus

This biopharmaceutical company develops and commercialises immuno-oncology therapies and biosimilar medicines for patients living with cancer and other serious inflammatory diseases.

Spherics

This pharmaceutical company develops oral drug delivery technologies to create improved therapeutic products for patients with central nervous system disorders and other medical conditions.